LUNG vs NVCR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

LUNG

55.1
AI Score
VS
LUNG Wins

NVCR

49.8
AI Score

Investment Advisor Scores

LUNG

55score
Recommendation
HOLD

NVCR

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG NVCR Winner
Revenue 43.34M 357.64M NVCR
Net Income -23.73M -86.80M LUNG
Gross Margin 78.0% 77.6% LUNG
Net Margin -54.8% -24.3% NVCR
Operating Income -22.01M -77.98M LUNG
ROE -60.6% -25.7% NVCR
ROA -20.7% -10.9% NVCR
Total Assets 114.73M 795.19M NVCR
Cash 55.84M 93.70M NVCR
Current Ratio 4.32 2.89 LUNG
Free Cash Flow -15.32M -17.45M LUNG

Relative Price Performance (Last 90 Days)

LUNG 1M: -19.7% · 3M: +23.6% NVCR 1M: -16.2% · 3M: -13.7%

Current Technical Phase

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.0 · Price: $1.83

NVCR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.5%), weak momentum, RSI 34

RSI (14): 34.3 · Price: $14.94

Fundamentals Snapshot

Metric LUNG NVCR
Market Cap — —
Forward P/E -1.9 -18.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.8% 0.8%
Operating Margin -0.4% -0.1%
EPS -1.15 -1.30
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.